Process and composition for treating disorders by administering isoxsurpine and choline
Patent 4351831 Issued on September 28, 1982. Estimated Expiration Date: 
January 30, 2001. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
January 30, 2001. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorsApplicationNo. 06/229704 filed on 01/30/1981US Classes:514/77, Inner salt (e.g., betaine, etc.)514/78, Lecithins514/922SIDE EFFECT REDUCTION BY INCORPORATION OF A SECOND DESIGNATED INGREDIENTExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassesA61K 33/00 (20060101)A61K 31/14 (20060101) A61K 31/445 (20060101) A61K 31/415 (20060101) A61K 31/55 (20060101) A61K 31/54 (20060101) A61K 31/495 (20060101) AbstractCholine or a natural or synthetic compound that dissociates to form choline is administered to a patient concomitantly with a drug in order to potentiate the effect of the drug by increasing acetylcholine levels in the brain or other tissues, and/or to suppress, or block the development of, unwanted side effects of the drug, by increasing acetylcholine levels in the brain or other tissues.Other References
| |
